Warner-lambert Company

Institut De Recherche Jouveinal S.a.

Jouveinal

Yves Pascal

Alain A Calvet

Henry Jacobelli

Adrian Payne

Jean-Louis Junien

Bernard Gaudilliere

Catherine Burnouf

Svein Dahl

Indres Moodley

Svein G Dahl

Phosphodiesterase 4-inhibiting diazepinoindolones

Diazepinoindoles as phosphodiesterase 4 inhibitors

The invention relates to diazepinoindoles of formula: ##STR1## in which R is hydrogen, lower alkyl or lower alkoxy; A is aryl or nitrogen-containing heteroaryl, each of which is optionally substituted by from one to three groups of halogen, lower alkyl, haloalkyl, lower alkoxy and acetamido, or their racemic forms, isomers or pharmaceutically acceptable salts, wherein for the racemic forms of the (S) configuration, A is not phenyl, haloalkyl, or 2-indolyl when R is hydrogen, and for the racemic forms of the (R) configuration, A is not 2-indolyl when R is hydrogen. Also, the invention relates to a method for inhibiting cyclic nucleotide phosphodiesterase activity by administering these compounds to a subject in an amount which is therapeutically effective to inhibit cyclic nucleotide phosphodiesterase activity.

Diazepinoindoles as phosphodiesterase IV inhibitors

Growing community of inventors

Rueil-Malmaison, France

Yves Pascal